These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. IL-14 and IL-16 are expressed in the thyroid of patients with either Graves' disease or Hashimoto's thyroiditis. Kemp EH; Ajjan RA; Metcalfe RA; Watson PF; Weetman AP Clin Endocrinol (Oxf); 2015 Nov; 83(5):726-32. PubMed ID: 25940130 [TBL] [Abstract][Full Text] [Related]
26. Thyroid autoantigen-induced lymphocyte proliferation in Graves' disease and Hashimoto's thyroiditis. Weetman AP; Gunn C; Hall R; McGregor AM J Clin Lab Immunol; 1985 May; 17(1):1-6. PubMed ID: 3876444 [TBL] [Abstract][Full Text] [Related]
27. Expression of the costimulatory molecule B7/BB1 in autoimmune thyroid disease. Tandon N; Metcalfe RA; Barnett D; Weetman AP Q J Med; 1994 Apr; 87(4):231-6. PubMed ID: 7516083 [TBL] [Abstract][Full Text] [Related]
28. Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' disease. Roura-Mir C; Catálfamo M; Sospedra M; Alcalde L; Pujol-Borrell R; Jaraquemada D Eur J Immunol; 1997 Dec; 27(12):3290-302. PubMed ID: 9464817 [TBL] [Abstract][Full Text] [Related]
29. Protection of thyroid cancer cells by complement-regulatory factors. Yamakawa M; Yamada K; Tsuge T; Ohrui H; Ogata T; Dobashi M; Imai Y Cancer; 1994 Jun; 73(11):2808-17. PubMed ID: 7514955 [TBL] [Abstract][Full Text] [Related]
30. Expression of the Hermes-1 (CD44) and ICAM-1 (CD54) molecule on the surface of thyroid cells from patients with Graves' disease. Fukazawa H; Yoshida K; Ichinohasama R; Sawai T; Hiromatsu Y; Mori K; Kikuchi K; Aizawa Y; Abe K; Wall JR Thyroid; 1993; 3(4):285-9. PubMed ID: 7509669 [TBL] [Abstract][Full Text] [Related]
31. Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease. Ross PV; Koenig RJ; Arscott P; Ludgate M; Waier M; Nelson CC; Kaplan MM; Baker JR J Clin Endocrinol Metab; 1993 Aug; 77(2):433-8. PubMed ID: 8345048 [TBL] [Abstract][Full Text] [Related]
32. Thyrocyte targets and effectors of autoimmunity: a role for death receptors? Hammond LJ; Palazzo FF; Shattock M; Goode AW; Mirakian R Thyroid; 2001 Oct; 11(10):919-27. PubMed ID: 11716038 [TBL] [Abstract][Full Text] [Related]
33. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells. Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195 [TBL] [Abstract][Full Text] [Related]
34. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism. Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210 [TBL] [Abstract][Full Text] [Related]
35. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells. Hakulinen J; Meri S Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832 [TBL] [Abstract][Full Text] [Related]
36. Immune complex deposits in thyroid glands of patients with Graves' disease: I. Complement system in serum and thyroid gland of patients with Graves' disease. Fujiwara H; Torisu M; Koitabashi Y; Baba T; Esaki H Clin Immunol Immunopathol; 1981 Apr; 19(1):98-108. PubMed ID: 7011618 [No Abstract] [Full Text] [Related]
37. The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity. van den Berg CW; Harrison RA; Morgan BP Immunology; 1993 Mar; 78(3):349-57. PubMed ID: 7682985 [TBL] [Abstract][Full Text] [Related]